Julian Harrison Analyst PerformanceManaging Director at BTIG ResearchJulian Harrison is a stock analyst at BTIG Research in the medical sector, covering 13 publicly traded companies. Over the past year, Julian Harrison has issued 15 stock ratings, including buy and hold recommendations. While full access to Julian Harrison's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Julian Harrison's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings17 Last 3 YearsBuy Recommendations93.75% 15 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution16RatingsDistribution of strong buy, buy, hold, and sell ratings by Julian Harrison.RatingPercentageCount Strong Buy0.0%0 ratings Buy93.8%15 ratings Hold6.3%1 ratings Sell0.0%0 ratingsOut of 16 total stock ratings issued by Julian Harrison at BTIG Research, the majority (93.8%) have been Buy recommendations, followed by 6.3% Hold.Best & Worst CallsBest Call00.0%PTGXApr 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ13 companiesJulian Harrison, an analyst at BTIG Research, currently covers 13 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical13 companies100.0%Julian Harrison of BTIG Research specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE9 companies69.2%MED - DRUGS4 companies30.8% About Julian HarrisonJulian Harrison is a Managing Director and BTIG Biotechnology Analyst. Prior to BTIG, Julian was a Senior Analyst at Tekla Capital Management where he covered small- to large-cap biotechnology and pharmaceutical companies. Previously, he was a Clinical and Translational Research Assistant at Hospital for Special Surgery. Julian earned a BS in biology from Cornell University and an MS in health economics from Weill Cornell Medical College.Follow on LinkedIn Julian Harrison's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCLYMClimb Bio9/30/2025Boost Price Target$1.99$8.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics9/29/2025Downgrade$61.99$85.00Neutral$0.0000.00% ROIORKAOruka Therapeutics9/29/2025Reiterated Rating$15.20$56.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics9/29/2025Reiterated Rating$13.02$40.00Buy$0.0000.00% ROICLYMClimb Bio9/22/2025Reiterated Rating$2.32$7.00Buy$0.0000.00% ROINKTRNektar Therapeutics9/19/2025Reiterated Rating$58.76$100.00Buy$0.0000.00% ROIRZLTRezolute9/18/2025Reiterated Rating$7.71$17.00Buy$0.0000.00% ROIORKAOruka Therapeutics9/17/2025Boost Price Target$16.21$56.00Buy$0.0000.00% ROISYRESpyre Therapeutics9/16/2025Reiterated Rating$14.84$70.00Buy$0.0000.00% ROIMAZEMaze Therapeutics9/12/2025Boost Price Target$24.80$37.00Buy$0.0000.00% ROICGEMCullinan Therapeutics9/10/2025Reiterated Rating$6.47$32.00Buy$0.0000.00% ROIABVXAbivax9/9/2025Reiterated Rating$90.00$112.00Buy$0.0000.00% ROIMAZEMaze Therapeutics9/2/2025Initiated Coverage$14.49$30.00Buy$0.0000.00% ROITBPHTheravance Biopharma6/27/2025Boost Price Target$11.20$25.00Buy$0.0000.00% ROIAURAAura Biosciences10/18/2024Boost Price Target$11.25$24.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
